Globus Medical Stock Analysis

GMED Stock  USD 90.80  0.33  0.36%   
Globus Medical is undervalued with Real Value of 99.85 and Target Price of 97.85. The main objective of Globus Medical stock analysis is to determine its intrinsic value, which is an estimate of what Globus Medical is worth, separate from its market price. There are two main types of Globus Medical's stock analysis: fundamental analysis and technical analysis.
The Globus Medical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Globus Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Globus Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of Globus Medical was currently reported as 29.94. The company has Price/Earnings To Growth (PEG) ratio of 2.4. Globus Medical had not issued any dividends in recent years. Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people. To learn more about Globus Medical call David Paul at 610 930 1800 or check out https://www.globusmedical.com.

Globus Medical Quarterly Total Revenue

625.71 Million

Globus Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Globus Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Globus Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from investors.com: Comfort Systems Stock Looks Hot As It Cools Data Centers

Globus Medical Upcoming and Recent Events

20th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Globus Largest EPS Surprises

Earnings surprises can significantly impact Globus Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-11-03
2015-09-300.250.280.0312 
2014-10-30
2014-09-300.210.240.0314 
2014-02-26
2013-12-310.220.250.0313 
View All Earnings Estimates

Globus Medical Environmental, Social, and Governance (ESG) Scores

Globus Medical's ESG score is a quantitative measure that evaluates Globus Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Globus Medical's operations that may have significant financial implications and affect Globus Medical's stock price as well as guide investors towards more socially responsible investments.

Globus Medical Thematic Classifications

In addition to having Globus Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Obamacare Idea
Obamacare
Companies that count on Obamacare to take off
Obamacare Repeal Idea
Obamacare Repeal
Large healthcare related equities associated with Obamacare
Baby Boomer Prospects Idea
Baby Boomer Prospects
Mega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force

Globus Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-09-30
1.9 M
Norges Bank2024-06-30
1.8 M
Champlain Investment Partners, Llc2024-09-30
1.8 M
Gw&k Investment Management, Llc2024-09-30
1.8 M
Geneva Capital Management2024-09-30
1.6 M
Citadel Advisors Llc2024-09-30
1.6 M
William Blair Investment Management, Llc2024-09-30
1.6 M
Axa Sa2024-09-30
1.5 M
Van Berkom And Associates Inc2024-09-30
1.5 M
Vanguard Group Inc2024-09-30
10.6 M
Blackrock Inc2024-09-30
10.3 M
Note, although Globus Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Globus Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 12.32 B.

Globus Profitablity

The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.05  0.05 
Return On Capital Employed 0.03  0.03 
Return On Assets 0.03  0.03 
Return On Equity 0.04  0.03 

Management Efficiency

Globus Medical has return on total asset (ROA) of 0.0473 % which means that it generated a profit of $0.0473 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0222 %, meaning that it created $0.0222 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of January 18, 2025, Return On Tangible Assets is expected to decline to 0.05. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Globus Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 94.9 M, whereas Return On Tangible Assets are forecasted to decline to 0.05.
Last ReportedProjected for Next Year
Book Value Per Share 31.82  33.41 
Tangible Book Value Per Share 13.04  6.95 
Enterprise Value Over EBITDA 15.79  13.51 
Price Book Value Ratio 1.73  1.65 
Enterprise Value Multiple 15.79  13.51 
Price Fair Value 1.73  1.65 
Globus Medical benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Operating Margin
0.1767
Profit Margin
0.0369
Beta
1.169
Return On Assets
0.0473
Return On Equity
0.0222

Technical Drivers

As of the 18th of January 2025, Globus Medical retains the Risk Adjusted Performance of 0.1946, downside deviation of 1.1, and Market Risk Adjusted Performance of 1.4. Globus Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Globus Medical value at risk, and the relationship between the jensen alpha and semi variance to decide if Globus Medical is priced fairly, providing market reflects its last-minute price of 90.8 per share. Given that Globus Medical has jensen alpha of 0.3677, we strongly advise you to confirm Globus Medical's regular market performance to make sure the company can sustain itself at a future point.

Globus Medical Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Globus Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Globus Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Globus Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Globus Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Globus Medical Outstanding Bonds

Globus Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Globus Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Globus bonds can be classified according to their maturity, which is the date when Globus Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Globus Medical Predictive Daily Indicators

Globus Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Globus Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Globus Medical Corporate Filings

F4
14th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
8th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
4th of December 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
25th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
20th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
8th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
5th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Globus Medical Forecast Models

Globus Medical's time-series forecasting models are one of many Globus Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Globus Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Globus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Globus Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Globus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Globus Medical. By using and applying Globus Stock analysis, traders can create a robust methodology for identifying Globus entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.11  0.12 
Operating Profit Margin 0.10  0.09 
Net Profit Margin 0.09  0.09 
Gross Profit Margin 0.75  0.85 

Current Globus Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Globus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Globus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
97.85Buy15Odds
Globus Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Globus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Globus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Globus Medical, talking to its executives and customers, or listening to Globus conference calls.
Globus Analyst Advice Details

Globus Stock Analysis Indicators

Globus Medical stock analysis indicators help investors evaluate how Globus Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Globus Medical shares will generate the highest return on investment. By understating and applying Globus Medical stock analysis, traders can identify Globus Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow150.5 M
Long Term Debt417.4 M
Common Stock Shares Outstanding114.6 M
Total Stockholder EquityB
Tax Provision42.5 M
Quarterly Earnings Growth Y O Y42.231
Property Plant And Equipment Net646.9 M
Cash And Short Term Investments517.8 M
Cash467.3 M
Accounts Payable56.7 M
Net Debt53.1 M
50 Day M A83.43
Total Current Liabilities392.3 M
Other Operating Expenses1.4 B
Non Current Assets Total3.2 B
Forward Price Earnings26.3852
Non Currrent Assets Other78.6 M
Stock Based Compensation52.7 M

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance